Skip to main content
Log in

The effects of R-75,317 on antiglomerular basement membrane glomerulonephritis in rats

  • PAF and the Renal System
  • Published:
Lipids

Abstract

Platelet-activating factor (PAF) is a potent inflammatory mediator which is released by various inflammatory cells and produced by certain tissues, including the kidney. PAF has been shown to increase glomerular permeability to protein and to decrease glomerular filtration rate (GFR) by contracting mesangium. On the basis of these observations, it has been suspected that PAF may play a role as mediator of glomerular damage in glomerular nephritis. To examine this possibility, we studied the effects of a specific PAF antagonist, R-75,317, on the development of an experimental model of anti-glomerular basement membrane (anti-GBM) glomerulonephritis. Glomerulonephritis was initiated by injecting rabbit anti-rat GBM serum into rats. Proteinuria gradually developed after serum injection, plateaued at week 2, and remained at the high level of week 2 throughout the experimental period (6 wk). Chronic treatment with R-75,317 (10 mg/kg/day i.p.) tended to delay the onset of proteinuria and significantly accelerated the recovery phase. Creatinine clearance (Ccr) fell to 40% at week 3. R-75,317 treatment completely prevented this decline of Ccr. Histological changes in this model (glomerular hypertrophy, proliferation of mesangial matrix and interstitial fibrosis) were also ameliorated by the R-75,317 treatment. The results suggest that PAF may play a role in the development of glomerulonephritis and that PAF antagonists could be used in the treatment of human renal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AA:

arachidonic acid

Ccr:

creatinine clearance

GBM:

glomerular basement membrane

GFR:

glomerular filtration rate

NAG:

N-acetyl-β-D-glucosaminidase

PAF:

plateletactivating factor, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine

References

  1. Benveniste, J., Henson, P.M., and Cochrane, C.G. (1972)J. Exp. Med. 136, 1356–1377.

    Article  PubMed  CAS  Google Scholar 

  2. Chignard, M., Le Couedic, J.P., Vargaftig, B.B., and Benveniste, J. (1980)Br. J. Haematol. 46, 455–464.

    PubMed  CAS  Google Scholar 

  3. Camussi, G., Aglietta, M., Coda, R., Bussolino, F., Piacibello, W., and Tetta, C. (1981)Immunology 42, 191–199.

    PubMed  CAS  Google Scholar 

  4. Camussi, G., Tetta, C., Coda, R., Segoloni, G.P., and Vercellone, A. (1984)Kidney Int. 25, 73–81.

    PubMed  CAS  Google Scholar 

  5. Scherf, H., Nies, A.S., Schwertschlag, U., Hughes, M., and Gerber, J.G. (1986)Hypertension 8, 737–741.

    PubMed  CAS  Google Scholar 

  6. Badr, K.F., Deboer, D.K., Takahashi, K., Harris, R.C., Fogo, A., and Jacobson, H.R. (1989)Am. J. Physiol. 256, F35-F43.

    PubMed  CAS  Google Scholar 

  7. Pirotzky, E., Bidault, J., Burtin, C., Gubler, M.C., and Benveniste, J. (1984)Kidney Int. 26, 404–410.

    Google Scholar 

  8. McIntyre, T.M., Zimmerman, G.A., and Prescott, S. (1986)Proc. Natl. Acad. Sci. USA 83, 2204–2209.

    Article  PubMed  CAS  Google Scholar 

  9. Schlondorff, D., Goldwasser, P., Neuwirth, R., Satriano, J.A., and Clay, K.L. (1986)Am. J. Physiol. 250, F1123-F1127.

    PubMed  CAS  Google Scholar 

  10. Unanue, E.R., and Dixon, F.J. (1967)Adv. Immunol. 6, 1–90.

    PubMed  CAS  Google Scholar 

  11. Wilson, C.B., and Dixon, F.J. (1986) inThe Kidney, pp. 800–890, W. B. Saunders Co., Philadelphia.

    Google Scholar 

  12. Nakamura, N., Koike, H., and Oshima, T. (1987) European Patent Appl. EP 87301283.5(870213).

  13. Hammer, D.K., and Dixon, F.J. (1963)J. Exp. Med. 117, 1019–1040.

    Article  PubMed  CAS  Google Scholar 

  14. Silva, F.G., Hoyer, J.R., and Pirani, L. (1984)Lab. Invest. 51, 404–415.

    PubMed  CAS  Google Scholar 

  15. Unanue, E.R., and Dixon, F.J. (1964)J. Exp. Med. 119, 965–982.

    Article  PubMed  CAS  Google Scholar 

  16. Cochrane, C.G., Unanue, E.R., and Dixon, F.J. (1965)J. Exp. Med. 122, 99–116.

    Article  PubMed  CAS  Google Scholar 

  17. Pirotzky, E., Page, C., Morley, J., Bidault, J., and Benveniste, J. (1985)Agents and Actions 16, 17–18.

    Article  PubMed  CAS  Google Scholar 

  18. Perico, N., Delaini, F., Tagliaferri, M., Abbate, M., Cucchi, M., Bertani, T., and Remuzzi, G. (1988)Lab. Invest. 58, 163–171.

    PubMed  CAS  Google Scholar 

  19. Schwertschlag, U.S., Dennis, V.W., Tucker, J.A., and Camussi, G. (1988)Kidney Int. 34, 779–785.

    PubMed  CAS  Google Scholar 

  20. Bertani, T., Livio, M., Macconi, D., Morigi, M., Bisogno, G., Patrono, C., and Remuzzi, G. (1987)Kidney Int. 31, 1248–1256.

    PubMed  CAS  Google Scholar 

  21. Hebert, R.L., Sirois, P., Braquet, P., and Plane, G.E. (1987)Prostaglandins, Leukotrienes Med. 26, 189–202.

    Article  CAS  Google Scholar 

  22. Lianos, E.A., Andres, G.A., and Dunn, M.J. (1983)J. Clin. Invest. 72, 1439–1448.

    PubMed  CAS  Google Scholar 

  23. Badr, K.F., Schreiner, G.F., Wasserman, M., and Ichikawa, I. (1988)J. Clin. Invest. 81, 1702–1709.

    PubMed  CAS  Google Scholar 

  24. Weisman, S.M., Felsen, D., and Vaughan Jr., E.D. (1985)J. Pharmacol. Exp. Ther. 235, 10–15.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Miyamoto, M., Koike, H., Sada, T. et al. The effects of R-75,317 on antiglomerular basement membrane glomerulonephritis in rats. Lipids 26, 1316–1319 (1991). https://doi.org/10.1007/BF02536556

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02536556

Keywords

Navigation